Early intervention with almotriptan improves sustained pain-free response in acute migraine.
- 24 November 2003
- journal article
- research article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 43 (10) , 1075-1079
- https://doi.org/10.1046/j.1526-4610.2003.03208.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Migraine Medication Attributes Important for Patient Compliance: Concerns About Side Effects May Delay TreatmentHeadache: The Journal of Head and Face Pain, 2003
- Almotriptan is an Effective and Well-Tolerated Treatment for Migraine Pain: Results of A Randomized, Double-Blind, Placebo-Controlled Clinical TrialCephalalgia, 2002
- Migraine — Current Understanding and TreatmentNew England Journal of Medicine, 2002
- Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trialsThe Lancet, 2001
- Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum StudyHeadache: The Journal of Head and Face Pain, 2000
- Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum StudyHeadache: The Journal of Head and Face Pain, 2000
- Guidelines for Controlled Trials of Drugs in Migraine: Second EditionCephalalgia, 2000
- Acute Migraine Therapy: Do Doctors Understand What Patients With Migraine Want From Therapy?Headache: The Journal of Head and Face Pain, 1999
- The Long‐term Tolerability and Efficacy of Oral Zolmitriptan (Zomig, 31X90) in the Acute Treatment of Migraine. An International StudyHeadache: The Journal of Head and Face Pain, 1998
- Absorption of Effervescent Aspirin during MigraineBMJ, 1974